Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Not applicableStudy completedNCT03889509
What this trial is testing

A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis

Who this might be right for
Pulmonary Arterial HypertensionSystemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 63
Not applicableStudy completedNCT01431326
What this trial is testing

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Who this might be right for
AdenovirusAnesthesiaAnxiety+56 more
Daniel Benjamin 3,520
Not applicableLooking for participantsNCT07236970
What this trial is testing

Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic Sclerosis

Who this might be right for
Pulmonary HypertensionSystemic Sclerosis (SSc)Systemic Sclerosis-Associated PAH
Alejandro Cruz Utrilla 350
Testing effectiveness (Phase 2)Looking for participantsNCT06104228
What this trial is testing

129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Arterial HypertensionPulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)+1 more
Bastiaan Driehuys 20
Not applicableUnknownNCT03459716
What this trial is testing

Endothelial Biomarkers of Systemic Sclerosis-associated Pulmonary Hypertension

Who this might be right for
SclerodermaPulmonary Hypertension
Louisiana State University Health Sciences Center in New Orleans 56
Post-approval studies (Phase 4)UnknownNCT05828147
What this trial is testing

Anti-CD20 Antibodies for Treatment of SLE-PAH

Who this might be right for
Systemic Lupus ErythematosusPulmonary Arterial Hypertension
Chinese SLE Treatment And Research Group 50
Not applicableStudy completedNCT05703802
What this trial is testing

Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.

Who this might be right for
SepsisPre-EclampsiaGranulomatosis With Polyangiitis+4 more
University Hospital Muenster 30
Not applicableLooking for participantsNCT07184814
What this trial is testing

Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement

Who this might be right for
Takayasu Arteritis With Pulmonary Artery InvolvementPulmonary Arterial Hypertension Associated With Connective Tissue Disease
China-Japan Friendship Hospital 150
Testing effectiveness (Phase 2)Ended earlyNCT04053543
What this trial is testing

CXA-10 Study in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
PAH
Complexa, Inc. 33
Not applicableLooking for participantsNCT07217522
What this trial is testing

Rutgers University Study of the Genetics of Pulmonary Hypertension

Who this might be right for
Pulmonary HypertensionPulmonary Arterial HypertensionPulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)+5 more
Rutgers, The State University of New Jersey 10,000
Large-scale testing (Phase 3)Ended earlyNCT04084678
What this trial is testing

Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH

Who this might be right for
PAHPulmonary HypertensionHypertension+8 more
United Therapeutics 10
Testing effectiveness (Phase 2)WithdrawnNCT00323024
What this trial is testing

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
NITROX, LLC 72
Large-scale testing (Phase 3)Study completedNCT03626688
What this trial is testing

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Who this might be right for
PAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more
United Therapeutics 687
Large-scale testing (Phase 3)Ended earlyNCT02657356
What this trial is testing

Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST

Who this might be right for
Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Biogen 202
Testing effectiveness (Phase 2)Study completedNCT02290613
What this trial is testing

Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH)

Who this might be right for
Systemic SclerosisPulmonary Hypertension
Heidelberg University 38
Early research (Phase 1)Ended earlyNCT02981082
What this trial is testing

Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

Who this might be right for
Systemic SclerosisPulmonary; Hypertension
Robert Lafyatis 6
Testing effectiveness (Phase 2)Ended earlyNCT03449524
What this trial is testing

PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
PAH
Complexa, Inc. 69
Large-scale testing (Phase 3)WithdrawnNCT03726398
What this trial is testing

CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH

Who this might be right for
Interstitial Lung DiseaseSclerodermaPulmonary Hypertension
Franz Rischard, DO
Testing effectiveness (Phase 2)Study completedNCT01086540
What this trial is testing

Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

Who this might be right for
Systemic Sclerosis-Associated PAH
National Institute of Allergy and Infectious Diseases (NIAID) 57
Large-scale testing (Phase 3)UnknownNCT00864201
What this trial is testing

Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease

Who this might be right for
Hypertension, PulmonaryConnective Tissue Disease
Hamilton Health Sciences Corporation 10
Load More Results